Eddie Williams
Insider
First SEC filing: Jan. 2, 2018 · Latest: Jan. 2, 2018
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | BCAB | A | 23,500 | · | · | 60,200 Direct | +64.03% | Acquired | |
| June 13, 2024 | BCAB | A | 16,500 | · | · | 36,700 Direct | +81.68% | Acquired | |
| Dec. 31, 2023 | BCAB | A | 4,827 | · | · | 20,200 Direct | +31.40% | Acquired | |
| Sept. 30, 2023 | BCAB | A | 6,985 | · | · | 15,373 Direct | +83.27% | Acquired | |
| June 30, 2023 | BCAB | A | 3,958 | · | · | 8,388 Direct | +89.35% | Acquired | |
| June 14, 2023 | BCAB | A | 50,000 | · | · | 50,000 Direct | · | Acquired | |
| March 31, 2023 | BCAB | A | 4,430 | · | · | 4,430 Direct | · | Acquired | |
| June 16, 2022 | BCAB | A | 20,000 | · | · | 20,000 Direct | · | Acquired | |
| Jan. 7, 2022 | GYRE | A | 12,308 | · | · | 34,804 Direct | +54.71% | Acquired | (price as of 2026-10-05) |
| Dec. 16, 2021 | BCAB | A | 25,000 | · | · | 25,000 Direct | · | Acquired | |
| Oct. 1, 2021 | GYRE | A | 2,980 | · | · | 22,496 Direct | +15.27% | Acquired | (price as of 2026-10-05) |
| July 1, 2021 | GYRE | A | 1,414 | · | · | 19,516 Direct | +7.81% | Acquired | (price as of 2026-10-05) |
| June 9, 2021 | GYRE | A | 14,000 | · | · | 14,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 1, 2021 | GYRE | A | 1,215 | · | · | 18,102 Direct | +7.19% | Acquired | (price as of 2026-10-05) |
| Jan. 5, 2021 | GYRE | A | 940 | · | · | 16,887 Direct | +5.89% | Acquired | (price as of 2026-10-05) |
| Oct. 1, 2020 | GYRE | A | 1,380 | · | · | 15,947 Direct | +9.47% | Acquired | (price as of 2026-10-05) |
| July 1, 2020 | GYRE | A | 1,011 | · | · | 14,567 Direct | +7.46% | Acquired | (price as of 2026-10-05) |
| June 11, 2020 | GYRE | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 1, 2020 | GYRE | A | 2,717 | · | · | 13,556 Direct | +25.07% | Acquired | (price as of 2026-10-05) |
| March 4, 2020 | GYRE | P | 2,000 | $5.78 | $11,560 | 10,839 Direct | +22.63% | Acquired | -91.5% (price as of 2026-10-05) |
| Jan. 2, 2020 | GYRE | A | 1,743 | · | · | 8,839 Direct | +24.56% | Acquired | (price as of 2026-10-05) |
| Oct. 1, 2019 | GYRE | A | 2,418 | · | · | 7,096 Direct | +51.69% | Acquired | (price as of 2026-10-05) |
| July 1, 2019 | GYRE | A | 1,642 | · | · | 4,678 Direct | +54.08% | Acquired | (price as of 2026-10-05) |
| June 13, 2019 | GYRE | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 1, 2019 | GYRE | A | 1,364 | · | · | 3,036 Direct | +81.58% | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2018 | GYRE | A | 1,544 | · | · | 1,672 Direct | +1206.25% | Acquired | (price as of 2026-10-05) |
| June 13, 2018 | GYRE | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2018 | GYRE | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 14, 2023 | BCAB | Stock Option (Right to Buy) | Common Stock | $3.55 | June 14, 2033 | 50,000 | Acquired |
| June 16, 2022 | BCAB | Stock Option (right to buy) | Common Stock | $2.48 | June 16, 2032 | 20,000 | Acquired |
| Dec. 16, 2021 | BCAB | Stock Option (Right to Buy) | Common Stock | $19.57 | Dec. 16, 2031 | 25,000 | Acquired |
| June 9, 2021 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.55 | June 9, 2031 | 14,000 | Acquired |
| June 11, 2020 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.18 | June 11, 2030 | 5,000 | Acquired |
| June 13, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.46 | June 13, 2029 | 5,000 | Acquired |
| June 13, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock | $24.94 | June 13, 2028 | 5,000 | Acquired |
| Jan. 2, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock | $14.37 | Jan. 2, 2028 | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 2, 2018 | GYRE | Common Stock | 128 | Direct |